Myriad Genetics (MYGN) Capital Expenditures (QoQ) (2009 - 2026)
Myriad Genetics (MYGN) Capital Expenditures (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.89% |
| Dec 31, 2025 | -59.48% |
| Sep 30, 2025 | 293.33% |
| Jun 30, 2025 | -213.21% |
| Mar 31, 2025 | 47.22% |
| Dec 31, 2024 | 2.86% |
| Sep 30, 2024 | -71.07% |
| Jun 30, 2024 | 6,150.00% |
| Mar 31, 2024 | 97.22% |
| Dec 31, 2023 | -209.09% |
| Sep 30, 2023 | 128.09% |
| Jun 30, 2023 | -200.00% |
| Mar 31, 2023 | 60.96% |
| Dec 31, 2022 | -17.51% |
| Sep 30, 2022 | 164.18% |
| Jun 30, 2022 | 6.35% |
| Mar 31, 2022 | 85.29% |
| Dec 31, 2021 | -71.43% |
| Sep 30, 2021 | 370.45% |
| Jun 30, 2021 | -161.97% |